In summary, we found that SLC22A1 594709 and SLC47A1 rs2289669 polymorphisms may interact to affect the therapeutic efficacy of metformin in Chinese T2DM patients. This evidence concerns the gene SLC22A1 and type 2 diabetes mellitus.